Tags: Eli Lilly
Alphabet’s Isomorphic Labs Partners With Eli Lilly, Novartis to Accelerate AI-Driven Drug Discovery
Isomorphic Labs, a subsidiary of Alphabet Inc., is set to accelerate AI-driven drug discovery after it entered into strategic research collaboration agreements with Novartis AG and Eli Lilly & Co.
Novartis psoriasis drug tops J&J's Stelara in late-stage study
Novartis said on Friday its experimental psoriasis drug Cosentyx was better at clearing the rough skin patches associated with the disease than Johnson & Johnson's Stelara.
Novartis says three executives to leave after GSK, Lilly deals
Swiss drugmaker Novartis AG (NOVN.VX) said three members of its executive committee would leave the company following the completion of transactions with GlaxoSmithKline (GSK.L) and Eli Lilly (LLY.N) to divest three units.
EU to extend Zimmer, Biomet probe, clear Eli Lilly, Novartis deal: sources
EU antitrust regulators will open an extensive probe into Zimmer's (ZMH.N) $13.4 billion bid for Biomet, concerned that the creation of the world's second-largest orthopedic products group may hurt competition, three people familiar with the matter said on Thursday.





